Pharma & Healthcare

Migraine Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Migraine medication can provide headache relief for your pain. There are several types of migraine medications available, both over-the-counter (OTC) and prescription, that can help alleviate headache symptoms. The choice of medication depends on the type and severity of the headache, as well as other individual factors.
The global market for Migraine Medication was estimated to be worth US$ 5912 million in 2023 and is forecast to a readjusted size of US$ 7335.9 million by 2030 with a CAGR of 3.1% during the forecast period 2024-2030
One of the primary market drivers for migraine medication is the high prevalence of headaches and migraines among the global population. Headaches are one of the most common medical complaints, affecting a significant number of individuals across different age groups and demographics. Migraines, in particular, can be debilitating and significantly impact a person's quality of life, leading to a higher demand for effective headache medications. Additionally, the increasing awareness and understanding of headaches and migraines have contributed to the growth of the headache medicine market. As people become more informed about these conditions and their treatment options, they are more likely to seek medical help and utilize headache medications.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Migraine Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Migraine Medication by region & country, by Type, and by Application.
The Migraine Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Migraine Medication.
Market Segmentation
By Company
GSK
Teva
Pfizer
Amgen
Viatris
Allergan
Grunenthal
Eli Lilly
Johnson & Johnson
Bayer
Haleon
Tongde Pharmacy
Huazhong Pharmaceutical
Weisen Pharmaceutical
DIAO GROUP
Jiheng Pharmaceutical
Dirui Pharmaceutical
Segment by Type:
NSAIDs
Acetaminophen
Triptans
Others
Segment by Application
Drug Stores
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Migraine Medication manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Migraine Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Migraine Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Migraine Medication Product Introduction
1.2 Global Migraine Medication Market Size Forecast
1.3 Migraine Medication Market Trends & Drivers
1.3.1 Migraine Medication Industry Trends
1.3.2 Migraine Medication Market Drivers & Opportunity
1.3.3 Migraine Medication Market Challenges
1.3.4 Migraine Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Migraine Medication Players Revenue Ranking (2023)
2.2 Global Migraine Medication Revenue by Company (2019-2024)
2.3 Key Companies Migraine Medication Manufacturing Base Distribution and Headquarters
2.4 Key Companies Migraine Medication Product Offered
2.5 Key Companies Time to Begin Mass Production of Migraine Medication
2.6 Migraine Medication Market Competitive Analysis
2.6.1 Migraine Medication Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Migraine Medication Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Medication as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NSAIDs
3.1.2 Acetaminophen
3.1.3 Triptans
3.1.4 Others
3.2 Global Migraine Medication Sales Value by Type
3.2.1 Global Migraine Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Migraine Medication Sales Value, by Type (2019-2030)
3.2.3 Global Migraine Medication Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Stores
4.1.2 Hospitals
4.1.3 Others
4.2 Global Migraine Medication Sales Value by Application
4.2.1 Global Migraine Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Migraine Medication Sales Value, by Application (2019-2030)
4.2.3 Global Migraine Medication Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Migraine Medication Sales Value by Region
5.1.1 Global Migraine Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Migraine Medication Sales Value by Region (2019-2024)
5.1.3 Global Migraine Medication Sales Value by Region (2025-2030)
5.1.4 Global Migraine Medication Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Migraine Medication Sales Value, 2019-2030
5.2.2 North America Migraine Medication Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Migraine Medication Sales Value, 2019-2030
5.3.2 Europe Migraine Medication Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Migraine Medication Sales Value, 2019-2030
5.4.2 Asia Pacific Migraine Medication Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Migraine Medication Sales Value, 2019-2030
5.5.2 South America Migraine Medication Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Migraine Medication Sales Value, 2019-2030
5.6.2 Middle East & Africa Migraine Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Migraine Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Migraine Medication Sales Value
6.3 United States
6.3.1 United States Migraine Medication Sales Value, 2019-2030
6.3.2 United States Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Migraine Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Migraine Medication Sales Value, 2019-2030
6.4.2 Europe Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Migraine Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Migraine Medication Sales Value, 2019-2030
6.5.2 China Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Migraine Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Migraine Medication Sales Value, 2019-2030
6.6.2 Japan Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Migraine Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Migraine Medication Sales Value, 2019-2030
6.7.2 South Korea Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Migraine Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Migraine Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Migraine Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Migraine Medication Sales Value, 2019-2030
6.9.2 India Migraine Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Migraine Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GSK
7.1.1 GSK Profile
7.1.2 GSK Main Business
7.1.3 GSK Migraine Medication Products, Services and Solutions
7.1.4 GSK Migraine Medication Revenue (US$ Million) & (2019-2024)
7.1.5 GSK Recent Developments
7.2 Teva
7.2.1 Teva Profile
7.2.2 Teva Main Business
7.2.3 Teva Migraine Medication Products, Services and Solutions
7.2.4 Teva Migraine Medication Revenue (US$ Million) & (2019-2024)
7.2.5 Teva Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Migraine Medication Products, Services and Solutions
7.3.4 Pfizer Migraine Medication Revenue (US$ Million) & (2019-2024)
7.3.5 Amgen Recent Developments
7.4 Amgen
7.4.1 Amgen Profile
7.4.2 Amgen Main Business
7.4.3 Amgen Migraine Medication Products, Services and Solutions
7.4.4 Amgen Migraine Medication Revenue (US$ Million) & (2019-2024)
7.4.5 Amgen Recent Developments
7.5 Viatris
7.5.1 Viatris Profile
7.5.2 Viatris Main Business
7.5.3 Viatris Migraine Medication Products, Services and Solutions
7.5.4 Viatris Migraine Medication Revenue (US$ Million) & (2019-2024)
7.5.5 Viatris Recent Developments
7.6 Allergan
7.6.1 Allergan Profile
7.6.2 Allergan Main Business
7.6.3 Allergan Migraine Medication Products, Services and Solutions
7.6.4 Allergan Migraine Medication Revenue (US$ Million) & (2019-2024)
7.6.5 Allergan Recent Developments
7.7 Grunenthal
7.7.1 Grunenthal Profile
7.7.2 Grunenthal Main Business
7.7.3 Grunenthal Migraine Medication Products, Services and Solutions
7.7.4 Grunenthal Migraine Medication Revenue (US$ Million) & (2019-2024)
7.7.5 Grunenthal Recent Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Profile
7.8.2 Eli Lilly Main Business
7.8.3 Eli Lilly Migraine Medication Products, Services and Solutions
7.8.4 Eli Lilly Migraine Medication Revenue (US$ Million) & (2019-2024)
7.8.5 Eli Lilly Recent Developments
7.9 Johnson & Johnson
7.9.1 Johnson & Johnson Profile
7.9.2 Johnson & Johnson Main Business
7.9.3 Johnson & Johnson Migraine Medication Products, Services and Solutions
7.9.4 Johnson & Johnson Migraine Medication Revenue (US$ Million) & (2019-2024)
7.9.5 Johnson & Johnson Recent Developments
7.10 Bayer
7.10.1 Bayer Profile
7.10.2 Bayer Main Business
7.10.3 Bayer Migraine Medication Products, Services and Solutions
7.10.4 Bayer Migraine Medication Revenue (US$ Million) & (2019-2024)
7.10.5 Bayer Recent Developments
7.11 Haleon
7.11.1 Haleon Profile
7.11.2 Haleon Main Business
7.11.3 Haleon Migraine Medication Products, Services and Solutions
7.11.4 Haleon Migraine Medication Revenue (US$ Million) & (2019-2024)
7.11.5 Haleon Recent Developments
7.12 Tongde Pharmacy
7.12.1 Tongde Pharmacy Profile
7.12.2 Tongde Pharmacy Main Business
7.12.3 Tongde Pharmacy Migraine Medication Products, Services and Solutions
7.12.4 Tongde Pharmacy Migraine Medication Revenue (US$ Million) & (2019-2024)
7.12.5 Tongde Pharmacy Recent Developments
7.13 Huazhong Pharmaceutical
7.13.1 Huazhong Pharmaceutical Profile
7.13.2 Huazhong Pharmaceutical Main Business
7.13.3 Huazhong Pharmaceutical Migraine Medication Products, Services and Solutions
7.13.4 Huazhong Pharmaceutical Migraine Medication Revenue (US$ Million) & (2019-2024)
7.13.5 Huazhong Pharmaceutical Recent Developments
7.14 Weisen Pharmaceutical
7.14.1 Weisen Pharmaceutical Profile
7.14.2 Weisen Pharmaceutical Main Business
7.14.3 Weisen Pharmaceutical Migraine Medication Products, Services and Solutions
7.14.4 Weisen Pharmaceutical Migraine Medication Revenue (US$ Million) & (2019-2024)
7.14.5 Weisen Pharmaceutical Recent Developments
7.15 DIAO GROUP
7.15.1 DIAO GROUP Profile
7.15.2 DIAO GROUP Main Business
7.15.3 DIAO GROUP Migraine Medication Products, Services and Solutions
7.15.4 DIAO GROUP Migraine Medication Revenue (US$ Million) & (2019-2024)
7.15.5 DIAO GROUP Recent Developments
7.16 Jiheng Pharmaceutical
7.16.1 Jiheng Pharmaceutical Profile
7.16.2 Jiheng Pharmaceutical Main Business
7.16.3 Jiheng Pharmaceutical Migraine Medication Products, Services and Solutions
7.16.4 Jiheng Pharmaceutical Migraine Medication Revenue (US$ Million) & (2019-2024)
7.16.5 Jiheng Pharmaceutical Recent Developments
7.17 Dirui Pharmaceutical
7.17.1 Dirui Pharmaceutical Profile
7.17.2 Dirui Pharmaceutical Main Business
7.17.3 Dirui Pharmaceutical Migraine Medication Products, Services and Solutions
7.17.4 Dirui Pharmaceutical Migraine Medication Revenue (US$ Million) & (2019-2024)
7.17.5 Dirui Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Migraine Medication Industrial Chain
8.2 Migraine Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Migraine Medication Sales Model
8.5.2 Sales Channel
8.5.3 Migraine Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Migraine Medication Market Trends
Table 2. Migraine Medication Market Drivers & Opportunity
Table 3. Migraine Medication Market Challenges
Table 4. Migraine Medication Market Restraints
Table 5. Global Migraine Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Migraine Medication Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Migraine Medication Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Migraine Medication Product Type
Table 9. Key Companies Time to Begin Mass Production of Migraine Medication
Table 10. Global Migraine Medication Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Medication as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Migraine Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Migraine Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Migraine Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Migraine Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Migraine Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Migraine Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Migraine Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Migraine Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Migraine Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Migraine Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Migraine Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Migraine Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Migraine Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Migraine Medication Sales Value by Region (2019-2024) & (%)
Table 27. Global Migraine Medication Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Migraine Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Migraine Medication Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Migraine Medication Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Migraine Medication Products, Services and Solutions
Table 34. Revenue (US$ Million) in Migraine Medication Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. Teva Basic Information List
Table 37. Teva Description and Business Overview
Table 38. Teva Migraine Medication Products, Services and Solutions
Table 39. Revenue (US$ Million) in Migraine Medication Business of Teva (2019-2024)
Table 40. Teva Recent Developments
Table 41. Pfizer Basic Information List
Table 42. Pfizer Description and Business Overview
Table 43. Pfizer Migraine Medication Products, Services and Solutions
Table 44. Revenue (US$ Million) in Migraine Medication Business of Pfizer (2019-2024)
Table 45. Pfizer Recent Developments
Table 46. Amgen Basic Information List
Table 47. Amgen Description and Business Overview
Table 48. Amgen Migraine Medication Products, Services and Solutions
Table 49. Revenue (US$ Million) in Migraine Medication Business of Amgen (2019-2024)
Table 50. Amgen Recent Developments
Table 51. Viatris Basic Information List
Table 52. Viatris Description and Business Overview
Table 53. Viatris Migraine Medication Products, Services and Solutions
Table 54. Revenue (US$ Million) in Migraine Medication Business of Viatris (2019-2024)
Table 55. Viatris Recent Developments
Table 56. Allergan Basic Information List
Table 57. Allergan Description and Business Overview
Table 58. Allergan Migraine Medication Products, Services and Solutions
Table 59. Revenue (US$ Million) in Migraine Medication Business of Allergan (2019-2024)
Table 60. Allergan Recent Developments
Table 61. Grunenthal Basic Information List
Table 62. Grunenthal Description and Business Overview
Table 63. Grunenthal Migraine Medication Products, Services and Solutions
Table 64. Revenue (US$ Million) in Migraine Medication Business of Grunenthal (2019-2024)
Table 65. Grunenthal Recent Developments
Table 66. Eli Lilly Basic Information List
Table 67. Eli Lilly Description and Business Overview
Table 68. Eli Lilly Migraine Medication Products, Services and Solutions
Table 69. Revenue (US$ Million) in Migraine Medication Business of Eli Lilly (2019-2024)
Table 70. Eli Lilly Recent Developments
Table 71. Johnson & Johnson Basic Information List
Table 72. Johnson & Johnson Description and Business Overview
Table 73. Johnson & Johnson Migraine Medication Products, Services and Solutions
Table 74. Revenue (US$ Million) in Migraine Medication Business of Johnson & Johnson (2019-2024)
Table 75. Johnson & Johnson Recent Developments
Table 76. Bayer Basic Information List
Table 77. Bayer Description and Business Overview
Table 78. Bayer Migraine Medication Products, Services and Solutions
Table 79. Revenue (US$ Million) in Migraine Medication Business of Bayer (2019-2024)
Table 80. Bayer Recent Developments
Table 81. Haleon Basic Information List
Table 82. Haleon Description and Business Overview
Table 83. Haleon Migraine Medication Products, Services and Solutions
Table 84. Revenue (US$ Million) in Migraine Medication Business of Haleon (2019-2024)
Table 85. Haleon Recent Developments
Table 86. Tongde Pharmacy Basic Information List
Table 87. Tongde Pharmacy Description and Business Overview
Table 88. Tongde Pharmacy Migraine Medication Products, Services and Solutions
Table 89. Revenue (US$ Million) in Migraine Medication Business of Tongde Pharmacy (2019-2024)
Table 90. Tongde Pharmacy Recent Developments
Table 91. Huazhong Pharmaceutical Basic Information List
Table 92. Huazhong Pharmaceutical Description and Business Overview
Table 93. Huazhong Pharmaceutical Migraine Medication Products, Services and Solutions
Table 94. Revenue (US$ Million) in Migraine Medication Business of Huazhong Pharmaceutical (2019-2024)
Table 95. Huazhong Pharmaceutical Recent Developments
Table 96. Weisen Pharmaceutical Basic Information List
Table 97. Weisen Pharmaceutical Description and Business Overview
Table 98. Weisen Pharmaceutical Migraine Medication Products, Services and Solutions
Table 99. Revenue (US$ Million) in Migraine Medication Business of Weisen Pharmaceutical (2019-2024)
Table 100. Weisen Pharmaceutical Recent Developments
Table 101. DIAO GROUP Basic Information List
Table 102. DIAO GROUP Description and Business Overview
Table 103. DIAO GROUP Migraine Medication Products, Services and Solutions
Table 104. Revenue (US$ Million) in Migraine Medication Business of DIAO GROUP (2019-2024)
Table 105. DIAO GROUP Recent Developments
Table 106. Jiheng Pharmaceutical Basic Information List
Table 107. Jiheng Pharmaceutical Description and Business Overview
Table 108. Jiheng Pharmaceutical Migraine Medication Products, Services and Solutions
Table 109. Revenue (US$ Million) in Migraine Medication Business of Jiheng Pharmaceutical (2019-2024)
Table 110. Jiheng Pharmaceutical Recent Developments
Table 111. Dirui Pharmaceutical Basic Information List
Table 112. Dirui Pharmaceutical Description and Business Overview
Table 113. Dirui Pharmaceutical Migraine Medication Products, Services and Solutions
Table 114. Revenue (US$ Million) in Migraine Medication Business of Dirui Pharmaceutical (2019-2024)
Table 115. Dirui Pharmaceutical Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Migraine Medication Downstream Customers
Table 119. Migraine Medication Distributors List
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Migraine Medication Product Picture
Figure 2. Global Migraine Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Migraine Medication Report Years Considered
Figure 5. Global Migraine Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Migraine Medication Revenue in 2023
Figure 7. Migraine Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. NSAIDs Picture
Figure 9. Acetaminophen Picture
Figure 10. Triptans Picture
Figure 11. Others Picture
Figure 12. Global Migraine Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Migraine Medication Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Drug Stores
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Others
Figure 17. Global Migraine Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Migraine Medication Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Migraine Medication Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Migraine Medication Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Migraine Medication Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Migraine Medication Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Migraine Medication Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Migraine Medication Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Migraine Medication Sales Value (%), (2019-2030)
Figure 30. United States Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 36. China Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 38. China Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 48. India Migraine Medication Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Migraine Medication Sales Value by Type (%), 2023 VS 2030
Figure 50. India Migraine Medication Sales Value by Application (%), 2023 VS 2030
Figure 51. Migraine Medication Industrial Chain
Figure 52. Migraine Medication Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies